The Oncology Institute, Inc.TOINASDAQ

Revenue (LTM)

$503M

+27.8% YoY

Net Income (LTM)

$-61M

+6.3% YoY

Free Cash Flow

$-28M

Revenue CAGR (5Y)

+25.4%

Marginsdeclining

FCF($0.0B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	203	252↑24.4%	324↑28.4%	393↑21.3%	503↑27.8%
Gross Profit	41	52↑27.5%	60↑14.4%	54↓9.4%	69↑28.7%
Operating Income	-46	-82↓78.7%	-77↑6.0%	-60↑21.9%	-36↑40.0%
Net Income	-11	0↑101.4%	-83↓54750.0%	-65↑22.2%	-61↑6.3%
EBITDA	-42	-68↓60.8%	-54↑19.7%	-54↑0.8%	-29↑45.9%
EPS Diluted	-0.16	-0.21↓31.2%	-0.92↓338.1%	-0.71↑22.8%	-0.54↑23.9%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	114	14↓87.7%	33↑139.0%	50↑48.3%	34↓32.4%
Total Current Assets	154	130↓15.3%	143↑10.0%	112↓21.7%	113↑0.3%
Total Assets	203	262↑28.6%	209↓20.0%	173↓17.5%	165↓4.7%
Total Current Liabilities	30	30↓0.3%	35↑17.1%	52↑50.1%	71↑35.9%
Total Liabilities	99	138↑39.5%	152↑9.9%	169↑11.1%	180↑6.7%
Total Equity	104	123↑18.3%	57↓53.7%	4↓93.7%	-16↓538.0%
Total Debt	0	108↑59014.2%	120↑10.6%	123↑2.9%	104↓15.8%
Net Debt	-114	94↑182.5%	86↓8.5%	73↓14.7%	70↓4.6%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-33	-62↓89.0%	-36↑41.2%	-27↑26.9%	-25↑7.4%
Capital Expenditure	-3	-6↓81.5%	-5↑17.4%	-4↑17.0%	-3↑15.5%
Free Cash Flow	-36	-67↓88.3%	-41↑39.2%	-30↑25.8%	-28↑8.4%
Stock-Based Comp	25	28↑12.8%	18↓35.7%	0	5
Net Change in Cash	109	-101↓192.7%	19↑119.3%	16↓16.9%	-16↓199.5%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance